Non-invasive care Market Alio as a non-invasive, multi-metric wearable platform for continuous monitoring of potassium, hematocrit, hemoglobin, heart rate, skin temperature and auscultation, highlighting potential to replace blood draws in dialysis settings and expand to related chronic care programs.

Dialysis focus Position the Alio Platform as a complementary solution for hemodialysis clinics seeking to improve patient safety, reduce procedure burdens, and enable remote monitoring, with opportunities to partner on procurement, clinical pilots, and integration with dialysis workflows.

FDA-cleared confidence Leverage FDA-cleared status and automated patient-specific calibration to build credibility with hospital systems, payers, and health networks, framing sales conversations around safety, data quality, and reduced need for invasive tests.

Tech ecosystem Highlight the scalable cloud-based platform and integrations (AWS, Google Cloud, analytics tools) to enterprise buyers, emphasizing data interoperability, security, and potential for predictive insights across multiple metrics.

Growth potential Explore expansion opportunities with health systems and distributors by offering bundled solutions, pilot programs, and scalable pricing for broader adoption across nephrology, critical care, and remote patient monitoring segments.